We tested the hypothesis that inhaled beclomethasone therapy for prevention of bronchopulmonary dysplasia (BPD) reduces pulmonary inflammation. As part of a randomized, placebo-controlled trial, interleukin-8 (IL-8) and interleukin-1 receptor antagonist (IL-1ra) concentrations in tracheal aspirates
โฆ LIBER โฆ
Respiratory and systemic effects of inhaled dexamethasone on ventilator dependant preterm infants at risk for bronchopulmonary dysplasia
โ Scribed by Marianne Pappagallo; Soraya Abbasi; Vinod K. Bhutan
- Book ID
- 110660071
- Publisher
- Springer-Verlag
- Year
- 1998
- Tongue
- English
- Weight
- 651 KB
- Volume
- 65
- Category
- Article
- ISSN
- 0019-5456
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Effects of early inhaled beclomethasone
โ
Gopal K. Gupta; Cynthia H. Cole; Soraya Abbasi; Serkalem Demissie; Charles Njini
๐
Article
๐
2000
๐
John Wiley and Sons
๐
English
โ 123 KB
๐ 1 views
Effects of inhaled beclomethasone compar
โ
P. Groneck; B. Goetze-Speer; C.P. Speer
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 57 KB
๐ 2 views
The purpose of this study was to compare the effects of daily inhaled beclomethasone (3 ร 500 ยตg) started on day 3 of life, with that of systemic dexamethasone (0.5 mg/kg/day) started between days 11-13 on clinical variables, lung inflammation, and pulmonary microvascular permeability in preterm inf